Showing results (61-70 of 244) with videos related to

Sort By:
Pageof 25
Hepatology International|August 12, 2009
A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinomaRobert G Gish, Stuart C Gordon, David Nelson, et al.
Journal of Clinical Gastroenterology|December 16, 2004
The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected]Mark V Galan, Jeffrey A Potts, Ann L Silverman, et al.
Journal of Clinical Gastroenterology|March 13, 2014
Is previous exposure to hepatitis B a risk factor for pancreatic cancer or hepatocellular carcinoma?Jeffrey Tang, Rishi Sharma, Lois Lamerato, et al.
World Journal of Gastrointestinal Pathophysiology|April 5, 2021
Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient populationAsim Kichloo, Shantanu Solanki, Khwaja F Haq, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|August 10, 2026
Multifaceted burden of short bowel syndrome for patients and caregivers: The landmark surveyJenny E Harrison, Syed-Mohammed Jafri, Roopa Vemulapalli, et al.
The American Journal of Managed Care|March 2, 2017
Treating Medicaid patients with hepatitis C: clinical and economic impactZobair Younossi, Stuart C Gordon, Aijaz Ahmed, et al.
The American Journal of Gastroenterology|December 14, 2019
Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsStuart C Gordon, Jeremy Fraysse, Suying Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 9, 2013
Cost-effectiveness of screening for chronic hepatitis C infection in the United StatesMark H Eckman, Andrew H Talal, Stuart C Gordon, et al.
Medicine|October 15, 2016
Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of careZobair M Younossi, Haesuk Park, Douglas Dieterich, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 3, 2016
The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all-oral regimens good value to society?Zobair M Younossi, Haesuk Park, Douglas Dieterich, et al.
Pageof 25